Novel trial designs: which agents and how do we test them?

Kelly WK. Novel trial designs: which agents and how do we test them? Urology. 2002 Sep; 60(3 Suppl 1):109-13; discussion 113-4.

View in: PubMed

subject areas

Antineoplastic Combined Chemotherapy Protocols
Clinical Trials as Topic
Hormones
Humans
Male
Prognosis
Prostate-Specific Antigen
Prostatic Neoplasms
Research Design

authors with profiles

William Kelly

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement